X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
oncology (16) 16
index medicus (5) 5
humans (4) 4
open-label (4) 4
phase-iii trial (4) 4
stem-cell transplantation (4) 4
1st-line treatment (3) 3
double-blind (3) 3
prognostic-factors (3) 3
cisplatin (2) 2
follow-up studies (2) 2
gemcitabine (2) 2
interferon-alpha (2) 2
neoplasm staging (2) 2
non-hodgkin-lymphoma (2) 2
randomized controlled-trial (2) 2
sunitinib (2) 2
tyrosine kinase inhibitors (2) 2
610 medicine & health (1) 1
acute lymphocytic-leukemia (1) 1
acute myeloid-leukemia (1) 1
adjuvant chemotherapy (1) 1
advanced esophagogastric cancer (1) 1
advanced-stage (1) 1
allogeneic transplantation (1) 1
amphotericin-b (1) 1
anaplastic lymphoma kinase (1) 1
autologous transplantation (1) 1
barretts-esophagus (1) 1
bilateral prophylactic mastectomy (1) 1
bone metastases (1) 1
cancer (1) 1
cancer and oncology (1) 1
cancer och onkologi (1) 1
cancer-patients (1) 1
carcinoma (1) 1
carcinoma, renal cell - diagnosis (1) 1
carcinoma, renal cell - therapy (1) 1
cell lung-cancer (1) 1
central-nervous-system (1) 1
cerebrospinal-fluid cytology (1) 1
chemotherapy (1) 1
chop (1) 1
cisplatin plus gemcitabine (1) 1
clinic for neurology (1) 1
clinical medicine (1) 1
colony-stimulating factors (1) 1
combination chemotherapy (1) 1
combined modality therapy (1) 1
comprehensive geriatric assessment (1) 1
consortium (1) 1
contralateral breast-cancer (1) 1
controlled-release oxycodone (1) 1
cyclophosphamide (1) 1
d2 gastrectomy (1) 1
dose intravenous methotrexate (1) 1
elderly-patients (1) 1
espen guidelines (1) 1
everolimus (1) 1
evidence-based recommendations (1) 1
extrahepatic cholangiocarcinoma (1) 1
factor receptor mutations (1) 1
fallopian-tube (1) 1
fentanyl buccal tablet (1) 1
growth-factor receptor (1) 1
health planning guidelines (1) 1
hematology; oncology (1) 1
her2-positive breast-cancer (1) 1
high-dose therapy (1) 1
high-risk (1) 1
high-risk women (1) 1
hilar cholangiocarcinoma (1) 1
human (1) 1
individual patient data (1) 1
indolent (1) 1
inotuzumab ozogamicin (1) 1
interferon (1) 1
international society (1) 1
international working group (1) 1
intrahepatic cholangiocarcinoma (1) 1
invasive aspergillosis (1) 1
iwg-mrt (1) 1
junctional cancer (1) 1
kidney cancer (1) 1
kidney neoplasms - diagnosis (1) 1
kidney neoplasms - therapy (1) 1
klinisk medicin (1) 1
leukemia, myeloid, chronic, atypical, bcr-abl negative (1) 1
leukemia, myeloid, chronic, atypical, bcr-abl negative - diagnosis (1) 1
leukemia, myeloid, chronic, atypical, bcr-abl negative - pathology (1) 1
leukemia, myeloid, chronic, atypical, bcr-abl negative - therapy (1) 1
lymph-node dissection (1) 1
lymphoma, follicular - diagnosis (1) 1
lymphoma, follicular - pathology (1) 1
lymphoma, follicular - therapy (1) 1
mammography (1) 1
medical and health sciences (1) 1
medical cannabis (1) 1
medicin och hälsovetenskap (1) 1
metaanalysis (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Annals of oncology : official journal of the European Society for Medical Oncology, ISSN 0923-7534, 09/2016, Volume 27, Issue suppl 5, pp. v142 - v142
Journal Article
Annals of oncology : official journal of the European Society for Medical Oncology, ISSN 0923-7534, 09/2016, Volume 27, Issue suppl 5, pp. v138 - v139
Journal Article
Annals of oncology : official journal of the European Society for Medical Oncology, ISSN 0923-7534, 09/2016, Volume 27, Issue suppl 5, pp. v140 - v141
Journal Article
Annals of oncology : official journal of the European Society for Medical Oncology, ISSN 0923-7534, 09/2016, Volume 27, Issue suppl 5, pp. v134 - v135
Journal Article
Annals of Oncology, ISSN 0923-7534, 2016, Volume 27, Issue suppl 5, pp. v136 - v137
Journal Article